- Home
- CZWI vs CHRS Comparison
CZWI vs CHRS Comparison
Compare CZWI & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZWI
- CHRS
- Stock Information
- Founded
- CZWI 1938
- CHRS 2010
- Country
- CZWI United States
- CHRS United States
- Employees
- CZWI N/A
- CHRS N/A
- Industry
- CZWI Savings Institutions
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CZWI Finance
- CHRS Health Care
- Exchange
- CZWI Nasdaq
- CHRS Nasdaq
- Market Cap
- CZWI 156.4M
- CHRS 186.0M
- IPO Year
- CZWI N/A
- CHRS 2014
- Fundamental
- Price
- CZWI $16.77
- CHRS $1.13
- Analyst Decision
- CZWI
- CHRS Strong Buy
- Analyst Count
- CZWI 0
- CHRS 4
- Target Price
- CZWI N/A
- CHRS $4.51
- AVG Volume (30 Days)
- CZWI 47.4K
- CHRS 1.3M
- Earning Date
- CZWI 10-27-2025
- CHRS 11-06-2025
- Dividend Yield
- CZWI 2.14%
- CHRS N/A
- EPS Growth
- CZWI N/A
- CHRS N/A
- EPS
- CZWI 1.29
- CHRS 1.34
- Revenue
- CZWI $58,987,000.00
- CHRS $277,728,000.00
- Revenue This Year
- CZWI N/A
- CHRS N/A
- Revenue Next Year
- CZWI $11.90
- CHRS $109.48
- P/E Ratio
- CZWI $13.05
- CHRS $0.84
- Revenue Growth
- CZWI N/A
- CHRS 152.07
- 52 Week Low
- CZWI $12.69
- CHRS $0.71
- 52 Week High
- CZWI $17.04
- CHRS $2.43
- Technical
- Relative Strength Index (RSI)
- CZWI 54.79
- CHRS 29.26
- Support Level
- CZWI $15.50
- CHRS $1.09
- Resistance Level
- CZWI $17.00
- CHRS $1.39
- Average True Range (ATR)
- CZWI 0.30
- CHRS 0.13
- MACD
- CZWI 0.07
- CHRS -0.05
- Stochastic Oscillator
- CZWI 57.33
- CHRS 5.59
About CZWI Citizens Community Bancorp Inc.
Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short- term investments; and funds provided from operations.
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.